Fiduciary Trust CO Amgen Inc Transaction History

Fiduciary Trust CO

  • $6.5 Billion
  • Q2 2024

A detailed history of Fiduciary Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Fiduciary Trust CO holds 51,972 shares of AMGN stock, worth $16.8 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
51,972
Previous 53,020 1.98%
Holding current value
$16.8 Million
Previous $15.1 Million 7.72%
% of portfolio
0.25%
Previous 0.24%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$262.75 - $319.31 $275,362 - $334,636
-1,048 Reduced 1.98%
51,972 $16.2 Million
Q1 2024

May 13, 2024
BUY
$268.87 - $324.56 $255,695 - $308,656
951 Added 1.83%
53,020 $15.1 Million
Q4 2023

Feb 12, 2024
SELL
$255.7 - $288.46 $1.83 Million - $2.07 Million
-7,162 Reduced 12.09%
52,069 $15 Million
Q3 2023

Nov 14, 2023
SELL
$218.65 - $271.46 $176,669 - $219,339
-808 Reduced 1.35%
59,231 $15.9 Million
Q2 2023

Aug 01, 2023
SELL
$214.27 - $253.37 $668,522 - $790,514
-3,120 Reduced 4.94%
60,039 $13.3 Million
Q1 2023

May 15, 2023
SELL
$225.79 - $275.2 $156,924 - $191,264
-695 Reduced 1.09%
63,159 $15.3 Million
Q4 2022

Feb 13, 2023
SELL
$229.03 - $291.01 $186,888 - $237,464
-816 Reduced 1.26%
63,854 $16.8 Million
Q3 2022

Nov 14, 2022
SELL
$224.46 - $253.15 $231,642 - $261,250
-1,032 Reduced 1.57%
64,670 $14.6 Million
Q2 2022

Aug 12, 2022
SELL
$230.71 - $256.74 $631,914 - $703,210
-2,739 Reduced 4.0%
65,702 $16 Million
Q1 2022

May 12, 2022
SELL
$219.27 - $242.57 $200,851 - $222,194
-916 Reduced 1.32%
68,441 $16.6 Million
Q4 2021

Feb 14, 2022
SELL
$198.88 - $227.6 $1.48 Million - $1.69 Million
-7,434 Reduced 9.68%
69,357 $15.6 Million
Q3 2021

Nov 12, 2021
SELL
$212.27 - $248.7 $570,581 - $668,505
-2,688 Reduced 3.38%
76,791 $16.3 Million
Q2 2021

Aug 16, 2021
SELL
$233.58 - $259.14 $2.59 Million - $2.87 Million
-11,067 Reduced 12.22%
79,479 $19.4 Million
Q1 2021

May 19, 2021
SELL
$221.91 - $258.6 $283,822 - $330,749
-1,279 Reduced 1.39%
90,546 $22.5 Million
Q4 2020

Jan 26, 2021
BUY
$216.38 - $257.67 $13,415 - $15,975
62 Added 0.07%
91,825 $21.1 Million
Q3 2020

Nov 13, 2020
SELL
$234.65 - $260.95 $448,181 - $498,414
-1,910 Reduced 2.04%
91,763 $23.3 Million
Q2 2020

Aug 13, 2020
BUY
$197.81 - $242.74 $110,377 - $135,448
558 Added 0.6%
93,673 $22.1 Million
Q1 2020

May 15, 2020
BUY
$182.24 - $241.7 $610,321 - $809,453
3,349 Added 3.73%
93,115 $18.9 Million
Q4 2019

Feb 04, 2020
SELL
$189.21 - $243.2 $164,612 - $211,584
-870 Reduced 0.96%
89,766 $21.6 Million
Q3 2019

Nov 12, 2019
BUY
$174.11 - $208.62 $589,014 - $705,761
3,383 Added 3.88%
90,636 $17.5 Million
Q2 2019

Aug 14, 2019
SELL
$166.7 - $195.41 $493,098 - $578,022
-2,958 Reduced 3.28%
87,253 $16.1 Million
Q1 2019

May 07, 2019
SELL
$180.87 - $203.88 $51,005 - $57,494
-282 Reduced 0.31%
90,211 $17.1 Million
Q4 2018

Jan 29, 2019
SELL
$178.4 - $208.25 $34,788 - $40,608
-195 Reduced 0.22%
90,493 $17.6 Million
Q3 2018

Nov 13, 2018
SELL
$185.29 - $208.89 $71,892 - $81,049
-388 Reduced 0.43%
90,688 $18.8 Million
Q2 2018

Aug 03, 2018
SELL
$166.05 - $186.51 $29,556 - $33,198
-178 Reduced 0.2%
91,076 $16.8 Million
Q1 2018

May 08, 2018
BUY
$169.43 - $198.0 $1.6 Million - $1.87 Million
9,425 Added 11.52%
91,254 $15.6 Million
Q4 2017

Jan 29, 2018
BUY
$168.79 - $188.59 $334,204 - $373,408
1,980 Added 2.48%
81,829 $14.2 Million
Q3 2017

Nov 02, 2017
BUY
$167.29 - $191.0 $13.4 Million - $15.3 Million
79,849
79,849 $14.9 Million

Others Institutions Holding AMGN

# of Institutions
3,054
Shares Held
409M
Call Options Held
7.19M
Put Options Held
6.26M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email